suramin has been researched along with nf 279 in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardanuy, U; Czeche, S; Damer, S; Lambrecht, G; Mutschler, E; Nickel, P; Niebel, B; Rettinger, J; Schmalzing, G | 1 |
| Büttner, C; Klapperstück, M; Lambrecht, G; Markwardt, F; Nickel, P; Schmalzing, G | 1 |
| Damer, S; Lambrecht, G; Müller, G; Nickel, P; Rettinger, J; Schmalzing, G | 1 |
| Braun, K; Ganso, M; Hildebrandt, C; Kassack, M; Lambrecht, G; Nickel, P; Rettinger, J; Schmalzing, G; Ullmann, H | 1 |
| Rettinger, J; Schmalzing, G | 1 |
| Krishtal, O; Lalo, U; Pankratov, Y; Verkhratsky, A | 1 |
| Cook, AK; Evans, RJ; Imig, JD; Inscho, EW; Vial, C | 1 |
| Kauffenstein, G; Kukulski, F; Lavoie, EG; Lecka, J; Legendre, C; Lévesque, SA; Munkonda, MN; Pelletier, J; Sévigny, J | 1 |
| Gordienko, DV; Harhun, MI; Povstyan, OV | 1 |
| Searl, TJ; Silinsky, EM | 1 |
| Giroud, C; Hammonds, J; Marin, M; Melikyan, GB; Spearman, P | 1 |
| Anyanwu, AC; Burant, CF; Goonewardena, SN; Hyman, MC; Kanthi, Y; Petrovic-Djergovic, D; Pinsky, DJ; Rattan, R; Robichaud, P; Visovatti, SH; Wang, J | 1 |
| Christensen, MG; Fagerberg, SK; Greve, AS; Johnsen, N; Praetorius, HA; Skals, M | 1 |
13 other study(ies) available for suramin and nf 279
| Article | Year |
|---|---|
NF279: a novel potent and selective antagonist of P2X receptor-mediated responses.
Topics: Adenosine Triphosphate; Animals; Colon; Guinea Pigs; In Vitro Techniques; Male; Oocytes; Purinergic P2 Receptor Antagonists; Rats; Suramin; Vas Deferens; Vasoconstriction; Xenopus laevis | 1998 |
Antagonism by the suramin analogue NF279 on human P2X(1) and P2X(7) receptors.
Topics: Animals; Female; Humans; Purinergic P2 Receptor Antagonists; Suramin; Xenopus laevis | 2000 |
The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor.
Topics: Adenosine Triphosphate; Animals; Female; Humans; Purinergic Antagonists; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X3; Receptors, Purinergic P2X4; Suramin; Xenopus laevis | 2000 |
NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors.
Topics: Animals; Benzenesulfonates; Guinea Pigs; Ileum; Male; Muscle Contraction; Muscle, Smooth; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2X; Suramin; Vas Deferens; Xenopus laevis | 2001 |
Desensitization masks nanomolar potency of ATP for the P2X1 receptor.
Topics: Adenosine Triphosphate; Affinity Labels; Animals; Binding, Competitive; Dose-Response Relationship, Drug; Electrophysiology; Kinetics; Models, Biological; Models, Chemical; Oocytes; Plasmids; Protein Binding; Receptors, Purinergic P2; Receptors, Purinergic P2X; Recombinant Fusion Proteins; Suramin; Thionucleotides; Time Factors; Xenopus | 2004 |
P2X receptor-mediated excitatory synaptic currents in somatosensory cortex.
Topics: Adenosine Triphosphate; Animals; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Nicotinic Antagonists; Organ Culture Techniques; Patch-Clamp Techniques; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyramidal Cells; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X; Serotonin Antagonists; Somatosensory Cortex; Suramin; Synapses; Synaptic Transmission | 2003 |
Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior.
Topics: Adenosine Triphosphate; Animals; Diuretics; Dose-Response Relationship, Drug; Furosemide; Gene Deletion; Kidney; Male; Mice; Mice, Knockout; Microcirculation; Perfusion; Pressure; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X; Renal Circulation; Suramin; Time Factors; Xanthines | 2003 |
Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Antigens, CD; Aorta, Thoracic; Apyrase; Benzenesulfonates; Cell Membrane; Chlorocebus aethiops; COS Cells; Humans; Hydrolysis; Mice; Mice, Knockout; Purinergic P2 Receptor Antagonists; Recombinant Proteins; Suramin; Transfection; Triazines | 2007 |
Purinoreceptor-mediated current in myocytes from renal resistance arteries.
Topics: Adenosine Triphosphate; Animals; Arteries; Kidney; Kinetics; Male; Membrane Potentials; Microdissection; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Organ Specificity; Osmolar Concentration; Patch-Clamp Techniques; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Inbred WKY; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Suramin | 2010 |
Modulation of purinergic neuromuscular transmission by phorbol dibutyrate is independent of protein kinase C in murine urinary bladder.
Topics: Adenosine Triphosphate; Animals; Calcium Channel Blockers; Calcium Channels; Electric Stimulation; Membrane Potentials; Mice; Neuromuscular Junction; Neurotransmitter Agents; Phorbol 12,13-Dibutyrate; Phorbol Esters; Protein Kinase C; Protein Kinase Inhibitors; Purinergic Agents; Purinergic P2X Receptor Antagonists; Receptors, Purinergic; Sodium Channel Blockers; Sodium Channels; Suramin; Synaptic Transmission; Urinary Bladder | 2012 |
P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
Topics: CD4-Positive T-Lymphocytes; Female; HEK293 Cells; HIV-1; Humans; Male; Purinergic P2X Receptor Antagonists; Receptors, CCR5; Receptors, CXCR4; Receptors, Purinergic P2X1; Suramin; Virus Internalization | 2015 |
Purinergic dysregulation in pulmonary hypertension.
Topics: Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Antihypertensive Agents; Apyrase; Arterial Pressure; Disease Models, Animal; Genetic Predisposition to Disease; Humans; Hydrolysis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Pulmonary Artery; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X1; Severity of Illness Index; Signal Transduction; Suramin; Vascular Remodeling; Ventricular Remodeling | 2016 |
P2X
Topics: Animals; Benzenesulfonates; Blood Platelets; Escherichia coli Infections; Hemolysin Proteins; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Purinergic P2X Receptor Antagonists; Pyelonephritis; Receptors, Purinergic P2X1; Sepsis; Suramin; Urinary Tract Infections; Uropathogenic Escherichia coli | 2019 |